Gainers
- MDJM Ltd (NASDAQ:MDJH) jumped 27.2% to $2.29 after gaining 10% on Tuesday.
- Allegheny Technologies Incorporated (NYSE:ATI) gained 14.3% to $21.50 after the company posted upbeat Q4 results and announced a $150 million buyback plan.
- Epizyme, Inc. (NASDAQ:EPZM) rose 12.6% to $1.3850. Epizyme recently announced pricing of a public offering of common stock.
- Helbiz, Inc. (NASDAQ:HLBZ) shares rose 12.4% to $3.44. Helbiz’s CEO bought 1 million shares at an average price of $3.64 per share.
- Brinker International, Inc. (NYSE:EAT) shares gained 10.1% to $38.24 after the company reported upbeat Q2 earnings.
- IceCure Medical Ltd (NASDAQ:ICCM) rose 9.8% to $2.8438 after jumping more than 10% on Tuesday. IceCure Medical said it sees preliminary FY21 revenues of $4.1 million.
- Constellation Energy Corp. (NASDAQ:CEG) surged 10% to $54.75. Constellation reported completion of separation from Exelon.
- Pharming Group N.V. (NASDAQ:PHAR) gained 7.9% to $9.98 after the company reported positive results of Phase II/III pivotal clinical study of leniolisib for the treatment of activated PI3K delta syndrome.
- Sally Beauty Holdings, Inc. (NYSE:SBH) gained 7.6% to $18.72 following upbeat Q1 earnings.
- Match Group, Inc. (NASDAQ:MTCH) surged 7.4% to $120.40 after the company reported worse-than-expected Q4 sales results and issued Q1 2022 revenue guidance below estimates.
- iStar Inc. (NYSE:STAR) jumped 6.8% to $23.60 as the company agreed to sell net lease asset portfolio for $3.07 billion.
- Advanced Micro Devices, Inc. (NASDAQ:AMD) rose 6.5% to $124.42 after the company reported better-than-expected Q4 results and issued sales guidance above estimates.
- Alphabet Inc. (NASDAQ:GOOGL) shares rose 6.4% to $2,928.00 after the company reported better-than-expected results for its fourth quarter. The company’s board also approved a 20-for-1 stock split.
- Xilinx, Inc. (NASDAQ:XLNX) rose 6.3% to $210.86 in sympathy with AMD after the company reported better-than-expected Q4 earnings results and issued Q1 and FY22 sales guidance above estimates.
